The UHM Vacation IPO is scheduled to open for subscription on June 4, 2026, and…
Bio Medica Laboratories IPO Date, Review, Price, Allotment Details
Bio Medica Laboratories IPO will open on May 21, 2026 and will close on May 25, 2026. This IPO is a book-built issue, where the company aims to raise around ₹[.] crores. The issue includes a fresh issue of ₹[.] crores along with an offer for sale of up to 3,76,800 equity shares having a face value of ₹10 each.
The price band for Bio Medica Laboratories IPO has been fixed at ₹[.] to ₹[.] per share. The quota allocation consists of 35% for retail investors, 50% for QIBs, and 15% for HNIs. The IPO is scheduled to be listed on NSE on May 28, 2026, while the allotment date is expected on May 26, 2026.
In terms of financial performance, the company reported revenue of ₹38.33 crores in 2025 against ₹15.34 crores in 2024. The company reported profit of ₹9.79 crores in 2025 compared to profit of ₹2.50 crores in 2024. As per the financials, investors may consider applying to the IPO for a long-term perspective.
Bio Medica Laboratories IPO Details
| IPO Open Date | May 21, 2026 |
| IPO Close Date | May 25, 2026 |
| Face Value | ₹10 Per Equity Share |
| IPO Price Band | ₹[.] to ₹[.] Per Share |
| Issue Size | Approx ₹[.] Crores, 37,71,600 Equity Shares |
| Fresh Issue | Approx ₹[.] Crores, 33,95,00 Equity Shares |
| Offer for Sale: | Approx 3,76,800 Equity Shares |
| Issue Type | Book build Issue |
| IPO Listing | NSE SME |
Bio Medica Laboratories IPO Dates
| IPO Open Date: | May 21, 2026 |
| IPO Close Date: | May 25, 2026 |
| Basis of Allotment: | May 26, 2026 |
| Refunds: | May 27, 2026 |
| Credit to Demat Account: | May 27, 2026 |
| IPO Listing Date: | May 28, 2026 |
| IPO Bidding Cut-off Time: | May 25, 2026 – 5 PM |
BIO MEDICA LABORATORIES LIMITED is a leading parenteral manufacturing company based in Central India, known for its strong focus on quality, innovation, and healthcare excellence. The company specializes in producing a wide range of parenteral formulations, including injectables for human and veterinary applications. Built on a foundation of Good Manufacturing Practices (GMP) and Good Laboratory Practices (GLP), BIO MEDICA ensures that every product meets strict international standards of safety, purity, and effectiveness. Its modern manufacturing facilities are equipped with advanced technology, enabling consistent production of high-quality injectable solutions for domestic as well as global markets.
The company offers a diverse portfolio of injectable products designed to meet the needs of hospitals, healthcare providers, and veterinary care sectors. With a growing export presence, BIO MEDICA LABORATORIES LIMITED continues to expand its global footprint by delivering reliable healthcare solutions worldwide. The organization is driven by a strong mission to improve health and well-being through innovative parenteral formulations for both humans and animals. Its vision is to become a globally recognized leader in the pharmaceutical manufacturing industry by maintaining excellence, sustainability, and continuous improvement in all aspects of its operations.
Related Posts
